Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK6 | Q00534 | 14/20 | 0.50 |
| ▸ | CDK4 | P11802 | 11/20 | 0.50 |
| ▸ | CCND1 | P24385 | 2/20 | 0.50 |
| ▸ | CCND3 | P30281 | 1/20 | 0.50 |
| ▸ | CDK2 | P24941 | 8/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.46 |
| ▸ | DYRK2 | Q92630 | 2/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.45 |
| ▸ | CSF1R | P07333 | 1/20 | 0.45 |
| ▸ | CDK1 | P06493 | 1/20 | 0.45 |
| ▸ | CDK9 | P50750 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650584 | 1.00 | CDK6 (0.50) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL21122400 | 0.88 | CDK4 (0.65) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL22650636 | 0.87 | CDK4 (0.64) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL29936656 | 0.85 | CDK4 (0.46) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL31590617 | 0.85 | CDK4 (0.46) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL22650587 | 0.85 | CDK6 (0.62) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL22650610 | 0.83 | CDK6 (0.61) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL22650512 | 0.82 | CDK6 (0.50) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL17489104 | 0.82 | CDK4 (0.70) | CDK6CDK4CCND1CCND3CDK2 | |
| SCHEMBL22650950 | 0.81 | CDK4 (0.48) | CDK6CDK4CCND1CCND3CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220296595-A1 | CDK INHIBITORS | GENENTECH, INC. | 2022-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296595-A1 | CDK INHIBITORS | CDKL1, CDK9, CDK6 | CDK6 3/4885CDK4 10/4885CCND1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.